Cargando…
In vivo effects of chemotherapy on oncogenic pathways in colorectal cancer
Patients with advanced colorectal cancer often are treated with systemic cytotoxic therapy using fluorouracil (5‐FU), oxaliplatin, irinotecan, and FOLFOX or FOLFIRI combination protocols. Additionally, signaling pathways that are active in colorectal cancer can be therapeutically targeted. Herein, w...
Autores principales: | Spartalis, Christoph, Schmidt, Eva Marina, Elmasry, Manal, Schulz, Gerald Bastian, Kirchner, Thomas, Horst, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676136/ https://www.ncbi.nlm.nih.gov/pubmed/31119819 http://dx.doi.org/10.1111/cas.14077 |
Ejemplares similares
-
Therapeutic and prognostic implications of NOTCH and MAPK signaling in bladder cancer
por: Schulz, Gerald B., et al.
Publicado: (2021) -
RBP7 is a clinically prognostic biomarker and linked to tumor invasion and EMT in colon cancer
por: Elmasry, Manal, et al.
Publicado: (2019) -
CYB5R1 links epithelial-mesenchymal transition and poor prognosis in colorectal cancer
por: Woischke, Christine, et al.
Publicado: (2016) -
Activation of pro-oncogenic pathways in colorectal hyperplastic polyps
por: Do, Catherine, et al.
Publicado: (2013) -
Multicolor lineage tracing reveals clonal architecture and dynamics in colon cancer
por: Lamprecht, Sebastian, et al.
Publicado: (2017)